Surrogate Outcomes

Surrogate outcomes, which are indirect measures used to predict the effects of an intervention on a patient's health, can provide valuable insights in studies where direct outcomes are difficult to measure. However, these outcomes need to be properly validated to ensure they are reliable indicators of true clinical benefits or risks.

In the context of rheumatology, where many diseases are chronic and have long-term impacts, surrogate outcomes can play a significant role in clinical trials and observational studies. Our working group has been actively engaged in exploring the use of surrogate outcomes in rheumatology, with a focus on ensuring their validity, reliability, and clinical meaningfulness.

Robin Christensen

Robin Christensen

Co-Chair

Prof-Marissa-Lassere-sml

Marissa Lassere

Co-Chair

Jasvinder-A-Singh-Final

Jasvinder A. Singh

Co-Chair

Kennedy Martin

Martin Kennedy

PRP

Working Group Publications

Working Group Members:

Interested in joining the working group as a member?

Please enter your name.
Please enter a message.
Scroll to Top